Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Kolmar Holdings VC team

Profile and portfolio

Parent Kolmar Holdings

Kolmar Holdings VC team is the corporate venture arm of Kolmar Holdings, a consumer goods and retail company. Sectors it names: biotech and life sciences, healthcare and digital health.

Every figure links to its source

Where it invests

Geography

Investment regionsS1

Key facts

FactValueStatusSource
Parent companyKolmar HoldingsSingle sourceS1
Parent industryConsumer goods and retailSingle sourceS1
StatusActiveSingle sourceS1
Capital sourceParent company onlySingle sourceS1

Fund vehicles

VehicleSizeSource
KB Investment global bio and platform fund (Kolmar commitment KRW 50bn)KRW 250bnS1

Portfolio

Public sources name 4 portfolio companies.S1

Every company on the Kolmar Holdings VC team list

4 companies, as named in the sources cited.S1 Read the firm's list.

  • Cell in Cells (셀인셀즈)
  • Dyne Medical Group (다인메디컬그룹)
  • ProEn Therapeutics (프로엔테라퓨틱스)
  • SciAl Bio (사이알바이오)

Sources

  1. S1Biotimes: Kolmar Group joins KRW 250bn fund to find global bio and platform companiesPress
  2. S3CEO Score Daily: Kolmar Holdings concentrates on ESG and pharmaceutical companies including MyIB and ProEn Therapeutics (2024-08-30)Press

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Kolmar Holdings VC team or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.